Zanubrutinib (naive CLL/SLL): Capsule 80 mg; Brukinsa® Page last updated: 30 June 2023 Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 879KB) Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 274KB)